Post job

Dicerna Pharmaceuticals overview

Industry
Pharmaceutical
Revenue
Headquarters
Employees
302
Founded in
Website
Organization type
Public
Social media
Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. The company is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are DCR-PHXC (for primary hyperoxaluria), DCR-undisclosed (for orphan genetic disease), DCR-PCSK9 (for cardiovascular disease), and DCR-HBV (for hepatitis B virus) among others.
Dicerna Pharmaceuticals is a medium pharmaceutical company with 302 employees and an annual revenue of $164.3M that is headquartered in Cambridge, MA.

Dicerna Pharmaceuticals's mission statement

To provide life-changing therapies to people living with rare and common diseases.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Dicerna Pharmaceuticals employee reviews

Be the first to review!

Do you work at Dicerna Pharmaceuticals?

Help job seekers learn about working at Dicerna Pharmaceuticals

On this page

Be the first to review Dicerna Pharmaceuticals

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Dicerna Pharmaceuticals?

The team at Dicerna Pharmaceuticals

  • The founders of Dicerna Pharmaceuticals are Douglas M. Fambrough III and James Jenson.
  • The key people at Dicerna Pharmaceuticals are Douglas M. Fambrough III and James Jenson.
Key people
Douglas M. Fambrough III
James Jenson

Dicerna Pharmaceuticals rankings

Dicerna Pharmaceuticals is ranked #18 on the Best Pharmaceutical companies to work for in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Dicerna Pharmaceuticals salaries

Average Dicerna Pharmaceuticals salary
$84,090
yearly
$40.43 hourly
Updated March 14, 2024

Rate Dicerna Pharmaceuticals' commitment to diversity and inclusion.

Zippia waving zebra

Do you work at Dicerna Pharmaceuticals?

Were you satisfied with Dicerna Pharmaceuticals' salary and benefits?

Dicerna Pharmaceuticals financial performance

10.0
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Dicerna Pharmaceuticals currently has 164.3M in revenue. Dicerna Pharmaceuticals's most recent quarter produced 63.0m (q3'2021).

Dicerna Pharmaceuticals annual revenue

$164M
$131M
$99M
$66M
$33M
$0
2012
2015
2017
2018
2019
2020

Highest paying Dicerna Pharmaceuticals competitors

Compare Dicerna Pharmaceuticals salaries to competitors, including Rigel Pharmaceuticals, Alnylam Pharmaceuticals, and Jounce Therapeutics. Employees at Rigel Pharmaceuticals earn the highest average yearly salary of $83,403. The salaries at Alnylam Pharmaceuticals average $81,014 per year, and the salaries at Jounce Therapeutics come in at $79,158 per year.
RankCompanyAverage salaryJobs
1$83,4030
2$81,0140
3$79,1580
4$65,1060
5$64,5620
6$45,6590

Are you an executive, HR leader, or brand manager at Dicerna Pharmaceuticals?

Claiming and updating your company profile on Zippia is free and easy.

Dicerna Pharmaceuticals FAQs

Search for jobs

Zippia gives an in-depth look into the details of Dicerna Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Dicerna Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Dicerna Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Dicerna Pharmaceuticals. The data presented on this page does not represent the view of Dicerna Pharmaceuticals and its employees or that of Zippia.

Dicerna Pharmaceuticals may also be known as or be related to DICERNA PHARMACEUTICALS INC, Dicerna Pharmaceuticals, Dicerna Pharmaceuticals Inc and Dicerna Pharmaceuticals, Inc.